🇮🇱 TRASTUZUMAB DERUXTECAN in Israel

TRASTUZUMAB DERUXTECAN (TRASTUZUMAB DERUXTECAN) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

TRASTUZUMAB DERUXTECAN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is TRASTUZUMAB DERUXTECAN approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for TRASTUZUMAB DERUXTECAN in Israel?

Marketing authorisation holder not available in our data.